伤科接骨片与健步虎潜丸在Lisfranc关节损伤术后康复治疗中的应用对比

目的: 比较研究伤科接骨片与健步虎潜丸在Lisfranc关节损伤术后康复治疗中的应用效果. 方法: 选取2010年10月—2012年5月,本院收治的Lisfranc关节损伤的68例患者.随机将患者分为伤科接骨片组和健步虎潜丸组,每组34例.两组患者均采用切开复位内固定手术进行治疗,伤科接骨片组患者给予口服伤科接骨片,4片/次,3次/d;健步虎潜丸组患者给予健步虎潜丸,10粒/次,2次/d.比较分析两组Lisfranc关节损伤患者术后足部功能评价、临床症状改善时间、不同时间骨痂X射线评分以及不良反应发生情况. 结果: 与健步虎潜丸组相比,伤科接骨片组患者足部功能评价总优良率明显提高,可达73.53%,患者肿胀和压痛等临床症状消失时间均明显缩短,分别为(5.58±2.41) d和(10.64±2.43) d;治疗后VAS评分明显降低,仅为(1.51±1.02)分;14,21,28 d骨痂X射线评分均明显提高,分别为(0.78±0.09)分,(1.34±0.25)分,(2.51±0.42)分,差异均具有统计学意义(P<0.05). 结论: 伤科接骨片对Lisfranc关节损伤,能够起到促进术后康复的功效,可以作为安全、有效的辅助治疗用药而临床推广.

Comparative Study of Effects of Shangke Jiegu Tablet and Jianbu Huqian Pill on Postoperative Rehabilitation of Patients with Lisfranc Joint Injury

Objective: To compare the efects of Shangke Jiegu tablet and Jianbu Huqian pill on postoperative rehabilitation of patients with Lisfranc joint injury. Method: Sixty-eight Lisfranc joint injury patients were selected from October 2010 to May 2012 in our hospital. The patients were randomly divided into Shangke Jiegu tablet group and Jianbu Huqian pill group of 34 patients each. All patients were treated with open reduction and internal fixation surgery. The patients in Shangke Jiegu plate group received 4 Shangke Jiegu tablets three times daily. The patients in Jianbu Huqian pill group received 10 Jianbu Huqian pills twice daily. The postoperative evaluation of foot function, the time of clinical symptom improvement, callus X-ray scores at different time and adverse events of the Lisfranc joint injury patients in two groups were compared and analyzed. Result: Compared with Jianbu Huqian pill group, the overall excellent ratio of foot function was significantly increased (73.53%), the disappear time of clinical symptoms including swelling and tenderness (5.58±2.41) d and (10.64±2.43) d was reduced significantly in Shangke Jiegu plate group. The VAS score of (1.51±1.02) points was reduced significantly after treatment. The callus X-ray scores at 14, 21 d and 28 d were (0.78±0.09) points, (1.34±0.25) points, (2.51±0.42) points, respectively, which were significantly improved (P<0.05). Conclusion: Shangke Jiegu tablet could promote the efficacy of postoperative rehabilitation of Lisfranc joint injury. It could be an safe and effective medicine for adjuvant therapy and it is worthy to be applied widely in clinic.